12.6
Vivos Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
10.0
FY23:
8.27
FY24:
9.02
FY25:
10.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.4
FY22:
−25.0
FY23:
−17.3
FY24:
−11.2
FY25:
−19.9
(positive)
Change from FY22 to FY24
millions USD
FY21:
–
FY22:
−25.6
FY23:
−20.5
FY24:
−10.6
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.3
FY22:
−23.8
FY23:
−13.6
FY24:
−11.1
FY25:
−21.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−20.3
FY22:
−23.8
FY23:
−13.6
FY24:
−11.1
FY25:
−21.2
All amounts in millions USD